Page 1 of Clinical Trials for ( Drug exemestane AND Aromasin ), 114 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin
Last Updated: July 13, 2010
Condition(s): Breast Neoplasms
2
Recruiting
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy
Last Updated: January 27, 2012
Condition(s): Metastatic ER+ Her2- Breast Cancer; Postmenopausal
3
Completed
Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease
Last Updated: February 24, 2009
Condition(s): Breast Cancer
4
Completed
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
Last Updated: October 13, 2011
Condition(s): Breast Neoplasms
5
Active, not recruiting
24 Months of Exemestane or Letrozole to Treat Breast Cancer
Last Updated: December 8, 2009
Condition(s): Breast Cancer
6
Recruiting
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women With Clinical Stage II and III Estrogen Receptor Positive Breast Cancer
Last Updated: August 6, 2008
Condition(s): Breast Cancer
7
Recruiting
A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM2)
Last Updated: December 2, 2011
Condition(s): Breast Cancer
8
Terminated
Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer
Last Updated: March 21, 2009
Condition(s): Breast Cancer
9
Completed
Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer
Last Updated: March 1, 2010
Condition(s): Ovarian Cancer
10
Active, not recruiting
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Last Updated: May 9, 2009
Condition(s): Breast Cancer
11
Active, not recruiting
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
Last Updated: November 6, 2010
Condition(s): Breast Cancer
12
Recruiting
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Last Updated: February 7, 2012
Condition(s): Breast Cancer
13
Active, not recruiting
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
Last Updated: December 13, 2011
Condition(s): Breast Cancer
14
Recruiting
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Last Updated: March 7, 2011
Condition(s): Her2 Negative Breast Cancer Patients
15
Terminated
Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer
Last Updated: January 24, 2012
Condition(s): Metastatic Breast Cancer
16
Active, not recruiting
Tamoxifen Citrate Alone or Ovarian Function Suppression and Tamoxifen Citrate or Exemestane in Treating Premenopausal Women Who Have Undergone Surgery for Breast Cancer
Last Updated: May 5, 2010
Condition(s): Breast Cancer
17
Active, not recruiting
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
Last Updated: May 9, 2009
Condition(s): Breast Cancer
18
Completed
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
Last Updated: April 18, 2011
Condition(s): Breast Cancer
19
Active, not recruiting
An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin
Last Updated: February 5, 2012
Condition(s): Breast Neoplasms
20
Not yet recruiting
ELBA: Exemestane and Lapatinib in Advanced Breast Cancer
Last Updated: November 19, 2009
Condition(s): Breast Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+exemestane+%28Aromasin%29

Page 1 of Clinical Trials for ( Drug exemestane AND Aromasin ), 114 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About